START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center

The START Center for Cancer Research (“START”), a global leader in early-phase oncology clinical trials, announces the expansion of its network with the acquisition of Carolina Urologic Research Center (“CURC”) the premier urologic clinical research site specializing in genitourinary (GU) oncology. This acquisition strengthens START’s capabilities in one of oncology’s fastest-growing disease areas. With an estimated 2.6 million new cases diagnosed each year, GU cancers now account for over 1 in 8 of all cancer diagnoses worldwide.

Click here to read entire article